TipRanks
Crescent Biopharma (DE:C68)
FRANKFURT:C68
Germany Market
C68
Crescent Biopharma
RESEARCH TOOLSreports

Crescent Biopharma (C68) Balance Sheet

2 Followers

Crescent Biopharma Balance Sheet

Crescent Biopharma's total assets for Q2 2026 were $182.76M, a decrease of -8.22% from the previous quarter. DE:C68 total liabilities were $19.50M for the fiscal quarter, a 27.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 240.29M$ 35.62M$ 45.32M$ 51.81M$ 94.35M
Total Liabilities
$ 37.28M$ 51.10M$ 6.90M$ 8.88M$ 12.74M
Total Equity Gross Minority
$ 203.01M$ -15.48M$ 38.41M$ 42.93M$ 81.60M
Other Metrics
Currency in USD

Crescent Biopharma Debt to Assets